DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Thyrocare Technologies Limited — Board Meeting Intimation

NSE 1 hr ago·22 Oct 2026, 10:30 am

Thyrocare Technologies

Thyrocare Technologies has announced that its board will meet on October 29, 2026, to review and approve the company's unaudited financial results for the third quarter of fiscal year 2026. This is a standard procedural update that signals the company is preparing to disclose its latest performance data to the public and regulatory authorities.

For investors, this development is significant as it will provide the first concrete data on Thyrocare's operational health and financial trajectory for the current fiscal period. The results will likely offer insights into the company's revenue growth, profitability, and cash flow, helping shareholders assess the effectiveness of its current business strategies.

Investors should watch for the release of the financial statements and any accompanying management commentary. Key metrics to focus on include quarterly revenue growth, operating margins, and any commentary on the demand for diagnostic services. This information will be crucial for evaluating the stock's near-term performance.